The estimated Net Worth of Enterprise Associates 14, L... is at least $22.5 Milione dollars as of 4 January 2022. Enterprise L owns over 31,916 units of Imara Inc stock worth over $22,164,392 and over the last 3 years Enterprise sold IMRA stock worth over $338,860.
Enterprise has made over 2 trades of the Imara Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Enterprise sold 31,916 units of IMRA stock worth $72,130 on 4 January 2022.
The largest trade Enterprise's ever made was selling 116,476 units of Imara Inc stock on 30 December 2021 worth over $266,730. On average, Enterprise trades about 74,196 units every 3 days since 2021. As of 4 January 2022 Enterprise still owns at least 3,507,024 units of Imara Inc stock.
You can see the complete history of Enterprise L stock trades at the bottom of the page.
Over the last 5 years, insiders at Imara Inc have traded over $7,889,059 worth of Imara Inc stock and bought 11,496,717 units worth $107,874,489 . The most active insiders traders include David M Mott, Lundbeck A S H e Capital Management, L.P.Ra .... On average, Imara Inc executives and independent directors trade stock every 23 days with the average trade being worth of $1,965,179. The most recent stock trade was executed by Michael Gray on 22 February 2023, trading 9,856 units of IMRA stock currently worth $46,028.
Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia.
Imara Inc executives and other stock owners filed with the SEC include: